UK markets open in 5 hours 52 minutes

AFC-HD AMS Life Science Co., Ltd. (2927.T)

Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
867.00+6.00 (+0.70%)
As of 09:44AM JST. Market open.
Currency in JPY

Valuation measures4

Market cap (intra-day) 12.10B
Enterprise value 23.56B
Trailing P/E 9.09
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.44
Price/book (mrq)0.89
Enterprise value/revenue 0.77
Enterprise value/EBITDA 7.70

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 313.29%
S&P500 52-week change 326.27%
52-week high 3968.00
52-week low 3753.00
50-day moving average 3893.08
200-day moving average 3837.75

Share statistics

Avg vol (3-month) 365.08k
Avg vol (10-day) 336.14k
Shares outstanding 514.06M
Implied shares outstanding 614.16M
Float 88.69M
% held by insiders 133.60%
% held by institutions 12.67%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 430
Forward annual dividend yield 43.48%
Trailing annual dividend rate 315.00
Trailing annual dividend yield 31.74%
5-year average dividend yield 43.19
Payout ratio 431.66%
Dividend date 3N/A
Ex-dividend date 429 Aug 2024
Last split factor 210:1
Last split date 329 Aug 2011

Financial highlights

Fiscal year

Fiscal year ends 31 Aug 2023
Most-recent quarter (mrq)29 Feb 2024

Profitability

Profit margin 4.80%
Operating margin (ttm)7.01%

Management effectiveness

Return on assets (ttm)2.97%
Return on equity (ttm)10.13%

Income statement

Revenue (ttm)27.68B
Revenue per share (ttm)1,973.76
Quarterly revenue growth (yoy)14.80%
Gross profit (ttm)N/A
EBITDA 3.02B
Net income avi to common (ttm)1.33B
Diluted EPS (ttm)94.71
Quarterly earnings growth (yoy)27.20%

Balance sheet

Total cash (mrq)10.3B
Total cash per share (mrq)733.28
Total debt (mrq)21.76B
Total debt/equity (mrq)159.63%
Current ratio (mrq)1.27
Book value per share (mrq)968.98

Cash flow statement

Operating cash flow (ttm)204M
Levered free cash flow (ttm)-3.04B